Targeting the chemokine-Treg axes in tumor immune evasion: from mechanisms to therapeutic opportunities
Cancer immunotherapy has transformed oncology, yet its clinical efficacy is often limited by immune evasion within the tumor microenvironment (TME). Regulatory T cells (Tregs), a key immunosuppressive lineage, potently inhibit effector T-cell prolifera…